Climb Bio (CLYM) Income from Non-Controlling Interests (2020 - 2022)

Climb Bio's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$13.6 million for Q1 2022.

• Quarterly Income from Non-Controlling Interests rose 26.87% year-over-year to -$13.6 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was -$52.5 million (changed N/A YoY) and the FY2021 annual result came in at -$47.6 million, down 130.32% from the prior year.
• Income from Non-Controlling Interests was -$13.6 million for Q1 2022 at Climb Bio, down from -$10.6 million in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at -$2.3 million in Q3 2020 and bottomed at -$18.6 million in Q1 2021.
• A 3-year average of -$11.6 million and a median of -$12.1 million in 2021 frame the typical range for Income from Non-Controlling Interests.
• Peak annual rise in Income from Non-Controlling Interests reached 28.35% in 2021, while the deepest fall reached 326.62% in 2021.
• Climb Bio's Income from Non-Controlling Interests stood at -$14.9 million in 2020, then climbed by 28.35% to -$10.6 million in 2021, then decreased by 27.72% to -$13.6 million in 2022.
• Business Quant data shows CLYM's Income from Non-Controlling Interests at -$13.6 million in Q1 2022, -$10.6 million in Q4 2021, and -$9.6 million in Q3 2021.